To Evaluate the Clinical Safety and Efficacy of Limbal Stem Cell for Treatment of Superficial Corneal Pathologies”.
Condition(s):Corneal Scars and OpacitiesLast Updated:June 21, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Corneal Scars and OpacitiesLast Updated:June 21, 2021Unknown status
Condition(s):Congenital Hereditary Endothelial Dystrophy of CorneaLast Updated:April 14, 2021Unknown status
Condition(s):MyopiaLast Updated:September 24, 2021Unknown status
Condition(s):Diabetic RetinopathyLast Updated:June 27, 2018Completed
Condition(s):Open Angle GlaucomaLast Updated:December 12, 2023Completed
Condition(s):Primary Congenital Glaucoma; Developmental Glaucoma; Infantile GlaucomaLast Updated:April 12, 2022Completed
Condition(s):Corneal Scars and OpacitiesLast Updated:February 26, 2019Unknown status
Condition(s):Infection, FungalLast Updated:July 26, 2017Unknown status
Condition(s):Corneal Injuries; Corneal Burns; Corneal Scars and OpacitiesLast Updated:March 6, 2018Unknown status
Condition(s):LeukomaLast Updated:August 9, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.